Resilience (Blue Ash) Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 1,400

Employees

  • Latest Deal Type
  • General Corporate Purpose

  • Latest Deal Amount
  • $867M

  • Investors
  • 27

Resilience (Blue Ash) General Information

Description

Operator of a biopharmaceutical manufacturing company intended to change the way medicine is produced. The company offers various customized manufacturing capabilities to serve the requirements of biopharmaceuticals at different stages of the drug development process, from pre-clinical development to commercial supply, ensuring its clients with customized and scalable processes and facilities for complex and novel medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10901 Kenwood Road
  • Blue Ash, OH 45242
  • United States
+1 (888)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 10901 Kenwood Road
  • Blue Ash, OH 45242
  • United States
+1 (888)

Resilience (Blue Ash) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience (Blue Ash) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. General Corporate Purpose 29-Oct-2025 $867M Completed Generating Revenue
8. Later Stage VC 01-Jan-2025 Completed Generating Revenue
7. Grant 03-Oct-2024 Completed Generating Revenue
6. Debt - General Completed Generating Revenue
5. Later Stage VC 10-Jan-2023 Completed Generating Revenue
4. Later Stage VC (Series D) 06-Jun-2022 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Aug-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Oct-2020 $755M $805M Completed Startup
1. Early Stage VC (Series A1) $50M $50M Completed Stealth
To view Resilience (Blue Ash)’s complete valuation and funding history, request access »

Resilience (Blue Ash) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B
Series A2 3,991,142 $0.000100 8% $2.25 $2.25 1x $2.25 2.57%
Series A1 22,088,402 $0.000100 8% $2.05 $2.05 1x $2.05 14.23%
To view Resilience (Blue Ash)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Resilience (Blue Ash) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical manufacturing company intended to change the way medicine is produced. The company offer
Other Pharmaceuticals and Biotechnology
Blue Ash, OH
1,400 As of 2026

Framingham, MA
 

Hercules, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resilience (Blue Ash) Competitors (2)

One of Resilience (Blue Ash)’s 2 competitors is Syner-G BioPharma Group, a Private Equity-Backed company based in Framingham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Syner-G BioPharma Group Private Equity-Backed Framingham, MA
Pacific BioLabs Corporation Hercules, CA
You’re viewing 2 of 2 competitors. Get the full list »

Resilience (Blue Ash) Patents

Resilience (Blue Ash) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4782551-A1 Methods, kits, and systems for identification of vector copy number and integration sites Pending 22-Jan-2025
US-20260209748-A1 Methods, kits, and systems for identification of vector copy number and integration sites Pending 22-Jan-2025
WO-2025184348-A1 Sterile centrifuge drive systems Pending 01-Mar-2024
WO-2025171291-A1 Bacterial strains for protein glycosylation Pending 08-Feb-2024
US-20260337659-A1 Detecting contaminants during therapy development and manufacture Pending 06-Dec-2023 C12Q1/6806
To view Resilience (Blue Ash)’s complete patent history, request access »

Resilience (Blue Ash) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resilience (Blue Ash) Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
RIT Capital Partners Asset Manager
U.S. Department of Health and Human Services Government
Global Health Investment Corporation Venture Capital Minority
Mubadala Investment Company Sovereign Wealth Fund Minority
Omega Funds Venture Capital Minority
You’re viewing 5 of 27 investors. Get the full list »

Resilience (Blue Ash) Investments & Acquisitions (13)

Resilience (Blue Ash)’s most recent deal was a Merger/Acquisition with Anjarium Biosciences. The deal was made on 03-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Anjarium Biosciences 03-Dec-2025 Merger/Acquisition Drug Delivery
Taiwan Bio-Manufacturing 26-Dec-2023 Buyout/LBO Business/Productivity Software
Joint Venture (Resilience / Lifera) 28-Aug-2023 Joint Venture Construction and Engineering
AstraZeneca (Manufacturing Base in West Chester, Ohio) 30-Jan-2023 Corporate Asset Purchase Buildings and Property
Cell Therapy Manufacturing Center 13-May-2022 Joint Venture Biotechnology
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Resilience (Blue Ash) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Taiwan Bio-Manufacturing Taipei City, Taiwan 2023
Therapure Biopharma Mississauga, Canada 1995

Resilience (Blue Ash) FAQs

  • When was Resilience (Blue Ash) founded?

    Resilience (Blue Ash) was founded in 2020.

  • Where is Resilience (Blue Ash) headquartered?

    Resilience (Blue Ash) is headquartered in Blue Ash, OH.

  • What is the size of Resilience (Blue Ash)?

    Resilience (Blue Ash) has 1,400 total employees.

  • What industry is Resilience (Blue Ash) in?

    Resilience (Blue Ash)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Resilience (Blue Ash) a private or public company?

    Resilience (Blue Ash) is a Private company.

  • What is Resilience (Blue Ash)’s current revenue?

    The current revenue for Resilience (Blue Ash) is .

  • How much funding has Resilience (Blue Ash) raised over time?

    Resilience (Blue Ash) has raised $3.32B.

  • Who are Resilience (Blue Ash)’s investors?

    RIT Capital Partners, U.S. Department of Health and Human Services, Global Health Investment Corporation, Mubadala Investment Company, and Omega Funds are 5 of 27 investors who have invested in Resilience (Blue Ash).

  • Who are Resilience (Blue Ash)’s competitors?

    Syner-G BioPharma Group and Pacific BioLabs are competitors of Resilience (Blue Ash).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process